We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

41 hedge funds and large institutions have $9.05M invested in Anixa Biosciences in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,460% more call options, than puts

Call options by funds: $78K | Put options by funds: $5K

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

0.52% less ownership

Funds ownership: 11.48% → 10.96% (-0.52%)

2% less funds holding

Funds holding: 42 → 41 (-1)

11% less capital invested

Capital invested by funds: $10.2M → $9.05M (-$1.16M)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

Holders
41
Holders Change
-1
Holders Change %
-2.38%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
12
Reduced
10
Closed
7
Calls
$78K
Puts
$5K
Net Calls
+$73K
Net Calls Change
+$36K

Top Buyers

Rank Fund Capital Flow
1
LFCM
Long Focus Capital Management
Puerto Rico
+$277K
2
Simplex Trading
Simplex Trading
Illinois
+$47.1K
3
KeyBank National Association
KeyBank National Association
Ohio
+$45.5K
4
US Bancorp
US Bancorp
Minnesota
+$38.9K
5
Morgan Stanley
Morgan Stanley
New York
+$36.9K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$311K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$110K
3
Two Sigma Investments
Two Sigma Investments
New York
-$108K
4
Citadel Advisors
Citadel Advisors
Florida
-$101K
5
VF
Virtu Financial
New York
-$84K
Name Holding Trade Value Shares
Change 		Change in
Stake
ATC
26
Adirondack Trust Company
New York
$19K – – –
First Manhattan
27
First Manhattan
New York
$17K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$16K +$8.98K +3,060 +105%
TWM
29
Tradition Wealth Management
Minnesota
$14K +$11.7K +4,000 +400%
CAPTRUST Financial Advisors
30
CAPTRUST Financial Advisors
North Carolina
$14K +$14.7K +5,000 New
Bank of America
31
Bank of America
North Carolina
$10K -$4.52K -1,540 -30%
SAM
32
Strategic Asset Management
Minnesota
$10K +$10.9K +3,700 New
Osaic Holdings
33
Osaic Holdings
Arizona
$4K -$1.47K -500 -26%
AWM
34
Accel Wealth Management
Iowa
$3K – – –
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$3K – – –
JP Morgan Chase
36
JP Morgan Chase
New York
$2K – – –
Wells Fargo
37
Wells Fargo
California
$2K +$3 +1 +0.1%
TAM
38
Tucker Asset Management
Colorado
$1.64K +$1.76K +600 New
AA
39
Ancora Advisors
Ohio
$1K – – –
LFG
40
Larson Financial Group
Missouri
$1K +$1.47K +500 New
Two Sigma Investments
41
Two Sigma Investments
New York
– -$108K -36,350 Closed
Citadel Advisors
42
Citadel Advisors
Florida
– -$101K -33,935 Closed
VF
43
Virtu Financial
New York
– -$84K -28,201 Closed
JF
44
Jump Financial
Illinois
– -$77K -26,000 Closed
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
– -$56.6K -19,300 Closed
ECM
46
ExodusPoint Capital Management
New York
– -$30K -10,029 Closed
CBFP
47
Cedar Brook Financial Partners
Ohio
– -$30K -10,000 Closed
1
2

ANIX Hedge Fund Activity: Q1 2022 in Review

41 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q1 2022, worth a combined $9.05M — down 11% from $10.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ANIX and 6 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 12 added.

The largest buyer was Long Focus Capital Management, adding an estimated $277K. The largest seller was Renaissance Technologies, cutting an estimated $311K.

  • 41 institutional investors held Anixa Biosciences (ANIX) as of Q1 2022, down from 42 in Q4 2021.
  • Funds reported $9.05M of Anixa Biosciences stock for Q1 2022, down 11% quarter-over-quarter.
  • 6 funds opened new Anixa Biosciences positions in Q1 2022 and 7 closed out, a net change of -1 holder.
  • The largest Anixa Biosciences buyer in Q1 2022 was Long Focus Capital Management, an estimated $277K added.
  • The largest Anixa Biosciences seller in Q1 2022 was Renaissance Technologies, an estimated $311K sold.

Based on aggregated 13F filings for Q1 2022.